At the end of 3rd Month

At the end of 6th month

TSH tested

TSH ≥10 mIU/ml (hypothriodism)

TSH ≤9 mIU/ml (normal)

p-value

TSH tested

TSH ≥10 mIU/ml (hypothriodism)

TSH ≤9 mIU/ml (normal)

p-value

n = 135

n = 12 (8.9%)

n = 123 (91.1%)

n = 115

n = 30 (26.1%)

n = 85 (73.9%)

Characteristic

Age (in years)

0.65

0.74

<15

1

0

0.0%

1

100.0%

1

0

0.0%

1

100.0%

15 - 24

21

4

19.0%

17

81.0%

17

4

23.5%

13

76.5%

25 - 34

36

2

5.6%

34

94.4%

31

7

22.6%

24

77.4%

35 - 44

33

3

9.1%

30

90.9%

31

10

32.3%

21

67.7%

45 - 54

19

2

10.5%

17

89.5%

18

6

33.3%

12

66.7%

55 - 64

21

1

4.8%

20

95.2%

13

2

15.4%

11

84.6%

>65

4

0

0.0%

4

100.0%

4

2

50.0%

2

50.0%

Sex

Female

48

8

16.7%

40

83.3%

0.02

38

7

18.4%

31

81.6%

0.15

Male

87

4

4.6%

83

95.4%

77

24

31.2%

53

68.8%

Medication Received

Ethiomide (ETH)

118

11

9.3%

107

90.7%

0.64

99

26

26.3%

73

73.7%

0.68

Para-amino salicylate sodium (PAS)

2

0

0.0%

2

100.0%

- -

2

1

50.0%

1

50.0%

0.97

Both PAS and ETH

15

1

6.7%

14

93.3%

0.75

14

4

28.6%

10

71.4%

0.75

Antiretroviral

drugs

19

2

10.5%

17

89.5%

0.79

19

9

47.4%

10

52.6%

0.72

TSH = thyroid stimulating hormone measured at mirco-international units per millilitre.

p-value for Pearson’s chi-square